Xtrackers MSCI USA Banks UCITS ETF 1D
- ISIN
- IE00BDVPTJ63
- Issuer
- Xtrackers
- TER
- 0.12%
- Latest closing price
- 26.80 GBP · Source: Yahoo
- Fund Size
- €25 m As of: Nov 22, 2026
- Domicile
- Ireland
- Distribution Policy
- Distributing
- Replication Method
- Physical
- Base Currency
- USD
- WKN / Ticker
- A2N6AF / XUFB
Closing price of the trading day shown, not a real-time price. Prices can differ by exchange and trading currency.
Data availability
Data is available for 5 of 5 areas for this fund.
- Master data (TER, index, size): As of: Nov 22, 2026
- Closing price: As of: Nov 20, 2026
- Price history (at least 20 prices): As of: Nov 20, 2026
- Holdings: As of: Nov 22, 2026
- Risk figures: As of: Nov 22, 2026
Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.
At a glance
Data as ofXtrackers MSCI USA Banks UCITS ETF 1D (ISIN IE00BDVPTJ63) is a fund from Xtrackers (fund type: ETF). Benchmark index: MSCI USA Banks 20/35 Capped. Its ongoing charges (TER) are 0.12% per year. The fund size is €25 m. Distribution policy: Distributing. Replication: Physical. Fund domicile: Ireland. Latest closing price: 26.80 GBP (as of Nov 20, 2026).
- Launch date 03.12.2018 (7 years)
- Number of Holdings 15
- Strategy Passive (index tracking)
- Base Currency USD
- Currency hedging No
- Distribution Policy Distributing
- Replication Method Physical
- Securities lending Yes
- Domicile IE
- UCITS Compliant Yes
Price development
Pure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.
Risk figures
- Volatility
- 18.74 %
- Annualised range of fluctuation of daily price changes.
- Max Drawdown
- −6.60 %
- Largest price decline from a peak to the following low within the period.
- Sharpe Ratio
- -2.20
- Return above the risk-free rate relative to volatility. Of limited significance over at most 12 months.
Own calculation from 30 daily closing prices from Oct 12, 2026 to Nov 20, 2026 (at most 12 months), calculated on Nov 22, 2026. Sharpe ratio uses an assumed risk-free rate of 2 % p.a.
The price history covers less than 12 months. The figures are therefore of limited significance and not comparable with annual figures from other sources.
The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.
Documents
We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.
Search documents at XtrackersTracking difference and tracking error
We have no comparison series stored for this fund’s index, so a tracking analysis is not possible.
What does the fund invest in?
As of 29.07.2026 · Source: justETF / etfdbSector Breakdown
-
Financials 100.0%
-
Other 0.0%
Country Breakdown
-
United States 100.0%
-
Other 0.0%
Holdings
Showing 10 holdings that together make up 94.5 % of fund assets. (out of 15 holdings in total).
| # | Name | Weight |
|---|---|---|
| 1 | JPMorgan Chase & Co. | 31.91 % |
| 2 | Bank of America Corp. | 17.00 % |
| 3 | Wells Fargo & Co. | 13.66 % |
| 4 | Citigroup, Inc. | 12.50 % |
| 5 | US Bancorp /MN | 5.11 % |
| 6 | PNC Financial Services Gp | 4.98 % |
| 7 | Truist Financial Corp. | 3.21 % |
| 8 | Fifth Third Bancorp | 2.61 % |
| 9 | M&T Bank | 1.78 % |
| 10 | Huntington Bancshares Inc | 1.73 % |
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.
Alternatives on the same index
Other ETFs tracking the MSCI USA Banks 20/35 Capped – cheapest first.Frequently asked questions about the Xtrackers MSCI USA Banks UCITS ETF 1D
All information without guarantee. It is provided for information purposes only and does not constitute investment advice.